JNK inhibitor IX restrains pancreatic cancer through p53 and p21

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 24,434 followers.

RRIDs were included in the Frontiers in Oncology paper "JNK inhibitor IX restrains pancreatic cancer throu…" (https://t.co/tsW1JewzwW). Thank you for making your #methodsmatter. #STMpublishing

10 Jan 2023

Reply Repost Favourite

JNK inhibitor IX restrains pancreatic cancer through p53 and p21 https://t.co/sfHBOt2vHR https://t.co/KYJp23CDsW

08 Dec 2022

Reply Repost Favourite

RT @FrontOncology: New research: JNK inhibitor IX restrains pancreatic cancer through p53 and p21: Novel treatment options for pancreatic c…

07 Dec 2022

Reply Repost Favourite

New research: JNK inhibitor IX restrains pancreatic cancer through p53 and p21: Novel treatment options for pancreatic cancer are desperately needed. De-regulated kinases can be regularly detected in pancreatic cancer. Multiple pathway… https://t.co/29NzB5

07 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.